机译:Mepolizumab Is an Effective Option in Severe Eosinophilic Asthma Regardless of Baseline Features: Single-Center Real-Life Data
Division of Immunology and Allergic Diseases, Department of Chest Diseases, Ankara University;
Department of Biostatistics, Ankara University School of Medicine, Ankara, Turkey;
Severe eosinophilic asthma; Mepolizumab; Real-life study; Treatment response; Asthma control;